Mostrar el registro sencillo del ítem

dc.contributor.authorGutierrez Urbon, José 
dc.contributor.authorGil-Navarro, Maria Victoria
dc.contributor.authorMoreno-Ramos, Francisco
dc.contributor.authorNuñez-Nuñez, Maria
dc.contributor.authorPaño-Pardo, Jose Ramon
dc.contributor.authorPeriañez-Parraga, Leonor
dc.date.accessioned2022-01-25T12:18:28Z
dc.date.available2022-01-25T12:18:28Z
dc.date.issued2019
dc.identifier.issn1130-6343
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/31072287es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15938
dc.description.abstractOBJECTIVE: To identify indicators of hospital use of antimicrobials from the benchmark analysis of consumption data between hospitals at the same level through the collective judgement of a group of experts. METHOD: A committee formed by members of the Spanish Societies of Hospital Pharmacy and Infectious Diseases and Clinical Microbiology prepared a proposal of indicators which was submitted to consensus by a panel of 21 experts on infectious diseases, microbiology and antimicrobial therapy, through a modified Delphi method. The panel underwent two rounds of scores by e-mail. Participants assigned a score from 1 (completely disagree) to 9 (completely agree) to the relevance of each indicator in four dimensions: scientific evidence, efficacy and safety, ecological impact and cost. Scores were processed according to the RAND- UCLA method. An indicator was considered to be relevant if at least one dimension other than cost obtained a median score equal to or higher than 7 without disagreement among the panel. RESULTS: The committee submitted an initial proposal of 14 indicators. After the first round of panel scores, one indicator was ruled out and two were modified for moving on to the second round. Finally, 13 indicators were considered relevant. CONCLUSIONS: Determining indicators of the hospital use of antimicrobial agents based on consumption can allow the antimicrobial stewardship programs to detect any potential problems with the use of antimicrobial agents, and to help guide their efforts in order to implement actions of improvement, as well as to assess the impact of the measures implemented.es
dc.language.isospaes
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshEvidence-Based Medicine*
dc.subject.meshHumans*
dc.subject.meshConsensus*
dc.subject.meshTreatment Outcome*
dc.subject.meshDrug Costs*
dc.subject.meshAnti-Infective Agents*
dc.titleIndicadores del uso hospitalario de antimicrobianos basados en el consumoes
dc.title.alternativeIndicadores del uso hospitalario de antimicrobianos basados en el consumo.
dc.typeArtigoes
dc.identifier.doi10.7399/fh.11163
dc.identifier.pmid31072287
dc.identifier.sophos32433
dc.issue.number3es
dc.journal.titleFarmacia Hospitalariaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Farmaciaes
dc.rights.accessRightsopenAccesses
dc.subject.decsresultado del tratamiento*
dc.subject.decsconsenso*
dc.subject.decscostos de medicamentos*
dc.subject.decshumanos*
dc.subject.decsmedicina basada en datos científicos*
dc.subject.decsantiinfecciosos*
dc.subject.keywordCHUACes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number43es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-ShareAlike 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-ShareAlike 4.0 International